Biologic Drugs With Established Pharmaceutical Class: PCSK9 Inhibitor
✉ Email this page to a colleague
Biologic Drugs With Established Pharmaceutical Class: PCSK9 Inhibitor
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Amgen, Inc. | REPATHA | evolocumab | Injection | 125522 | 2015-08-27 | ⤷ Sign Up | ⤷ Sign Up |
Amgen, Inc. | REPATHA | evolocumab | Injection | 125522 | 2015-08-27 | ⤷ Sign Up | ⤷ Sign Up |
Amgen, Inc. | REPATHA | evolocumab | Injection | 125522 | 2015-08-27 | ⤷ Sign Up | ⤷ Sign Up |
Amgen, Inc. | REPATHA | evolocumab | Injection | 125522 | 2015-08-27 | ⤷ Sign Up | ⤷ Sign Up |
Amgen, Inc. | REPATHA | evolocumab | Injection | 125522 | 2015-08-27 | ⤷ Sign Up | ⤷ Sign Up |
Amgen, Inc. | REPATHA | evolocumab | Injection | 125522 | 2015-08-27 | ⤷ Sign Up | ⤷ Sign Up |
Amgen, Inc. | REPATHA | evolocumab | Injection | 125522 | 2015-08-27 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |